SNYR Synergy CHC Corp. - Common Stock
$0,11
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla May 14, 2026
52 Haftlık Aralık
$0–$4
1% of range
Analist Derecelendirmesi
BUY
8 analysts
Fiyat Hedefi
$4
+3375% upside
P/E (TTM)
-0.1
ROE
69.5%
Net Kâr Marjı
-40.6%
SNYR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.11
Piyasa Değeri
$1M
P/E (TTM)
-0.1
EPS (TTM)
$-1.27
Gelir (TTM)
$30M
Temettü Verimi
—
ROE
69.5%
D/E Borç/Özsermaye
-1.1
52 Haftlık Aralık
$0 – $4
SNYR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$30M
2014-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.27
2017-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2015-12-31
→
2018-12-31
Marjlar
-40.6%
2014-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
SNYR
Akran Ortalaması
P/E (TTM)
-0.1
22.4
P/S (TTM) (F/S (TTM))
0.0
1.2
P/B (F/D)
-0.1
3.5
EV / EBITDA
-2.8
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
SNYR
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
66.8%
62.7%
Operating Margin (Faaliyet Kâr Marjı)
-27.8%
—
Net Profit Margin (Net Kâr Marjı)
-40.6%
-15.4%
ROA
-93.1%
-34.5%
ROE
69.5%
-28.8%
ROIC
-442.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
SNYR
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-1.1
—
Current Ratio (Cari Oran)
1.2
1.1
Quick Ratio (Cari Oran)
0.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
SNYR
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-12.8%
—
EPS YoY (EPS YB)
-67.4%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-66.5%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
SNYR
Akran Ortalaması
SNYR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
8 analist
- Güçlü Al 2 25,0%
- Al 5 62,5%
- Tut 1 12,5%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
1 analist · 2026-08-19
Düşük
$3.75
Yüksek
$3.75
Medyan hedef
$3.75
+3375,4%
Ortalama hedef
$3.75
+3375,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.16%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.23 | $0.04 | -0.27% |
| 31 Aralık 2025 | $-0.72 | $0.01 | -0.73% |
| 30 Eylül 2025 | $0.01 | $0.01 | -0.00% |
| 30 Haziran 2025 | $0.17 | $0.08 | 0.09% |
| 31 Mart 2025 | $0.10 | $0.07 | 0.03% |
| 31 Aralık 2024 | $0.01 | $0.10 | -0.09% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| SNYR | $21M | -1.5 | -12.8% | -40.6% | 69.5% | 66.8% |
| KVUE | $32.94B | 22.6 | -2.1% | 9.7% | 13.7% | 58.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30M | $35M | $43M | $29M | $34M | $36M | $35M | $13M | $9.2K | |
| Cost of Revenue | $10M | $11M | $11M | $9M | $11M | $10M | $10M | $5M | $5.6K | |
| Gross Profit | $20M | $24M | $32M | $20M | $23M | $26M | $25M | $8M | $3.5K | |
| SG&A Expense | $9M | $5M | $6M | $5M | $7M | $8M | $8M | $3M | $961.6K | |
| Operating Expenses | $29M | $18M | $21M | $28M | $28M | $24M | $22M | $8M | $961.6K | |
| Operating Income | $-8M | $6M | $11M | $-8M | $-5M | $2M | $3M | $486.0K | $-958.1K | |
| Interest Expense | · | $2M | $2M | · | $1M | $1M | $-2M | $-958.7K | · | |
| Interest Income | $15.1K | $1.5K | $1.6K | · | · | · | · | · | · | |
| Other Non-op | $29M | $18M | $21M | $1M | $1M | $1M | $3M | $8M | $2.0K | |
| Pretax Income | $-12M | $2M | $7M | $-9M | $-6M | $815.6K | $148.2K | $-7M | $-960.1K | |
| Income Tax | $117.5K | $102.1K | $235.0K | $-131.5K | $247.7K | $316.0K | $944.4K | $389.9K | · | |
| Net Income | $-12M | $2M | $6M | $-9M | $-6M | $499.6K | $-796.2K | $-8M | $-960.1K | |
| EPS (Basic) | $-1.27 | $0.28 | $0.86 | $-0.10 | $-0.07 | $0.01 | · | · | · | |
| EPS (Diluted) | $-1.27 | $0.28 | $0.86 | $-0.10 | $-0.07 | $0.01 | · | · | · | |
| Shares (Basic) | 9,722,552 | 7,588,095 | 7,373,745 | 89,883,194 | 89,862,683 | 89,241,212 | · | · | · | |
| Shares (Diluted) | 9,722,552 | 7,630,501 | 7,373,745 | · | 89,862,683 | 89,241,212 | · | · | · | |
| EBITDA | $-8M | $6M | · | · | $-5M | $2M | $3M | $486.0K | · |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $687.9K | $632.5K | $1M | $459.7K | $2M | $3M | $4M | $338 | |
| Receivables | $3M | $5M | $2M | $1M | $4M | $4M | $2M | $4M | $2.9K | |
| Inventory | $4M | $2M | $4M | $2M | $3M | $3M | $1M | $686.7K | $26.1K | |
| Prepaid Expense | $351.0K | $2M | $798.0K | $186.1K | $828.8K | $1M | $1M | $422.4K | $10.0K | |
| Other Current Assets | · | · | · | · | $828.8K | · | · | · | · | |
| Current Assets | $10M | $16M | $12M | $5M | $9M | $10M | $7M | $9M | $55.4K | |
| PP&E (Net) | · | · | · | $135.9K | $269.8K | $293.2K | $257.4K | $12.0K | · | |
| PP&E (Gross) | · | · | · | $566.4K | $566.4K | $437.4K | $308.1K | $18.2K | · | |
| Accum. Depreciation | · | · | · | $430.5K | $296.7K | $144.2K | $50.7K | $6.2K | · | |
| Goodwill | · | · | · | · | $8M | $8M | $8M | $11M | · | |
| Intangibles | $150.0K | $283.3K | $416.7K | $7.6K | $3M | $6M | $5M | $6M | · | |
| Total Assets | $10M | $16M | $12M | $5M | $20M | $24M | $20M | $27M | $55.4K | |
| Accounts Payable | $6M | $5M | $12M | $5M | $8M | $4M | $5M | $5M | $74.6K | |
| Short-term Debt | $100.0K | $8M | $2M | · | · | · | · | · | · | |
| Current Liabilities | $8M | $17M | $14M | $10M | $10M | $7M | $12M | $15M | $181.0K | |
| Capital Leases | · | $8M | · | · | · | · | · | · | · | |
| Total Liabilities | $33M | $33M | $40M | $10M | $16M | $15M | $13M | $21M | $181.0K | |
| Long-term Debt | · | $11M | $15M | · | · | · | · | · | · | |
| Total Debt | $25M | $15M | · | · | · | · | $750.0K | $750.0K | · | |
| Common Stock | $114 | $87 | $76 | $899 | $899 | $899 | $888 | $817 | $621 | |
| Paid-in Capital | · | $8M | · | · | · | · | · | $14M | $867.0K | |
| Retained Earnings | $-56M | $-44M | $-46M | $-24M | $-15M | $-9M | $-9M | $-9M | $-1M | |
| Treasury Stock | $127.5K | $127.5K | $127.5K | · | · | · | · | · | · | |
| AOCI | $-154.3K | $-47.8K | $-102.5K | $11.4K | $179.1K | $-78.0K | $16.0K | · | · | |
| Stockholders' Equity | $-23M | $-17M | $-27M | $-5M | $4M | $9M | $7M | $5M | $-125.7K | |
| Liabilities + Equity | $10M | $16M | $12M | $5M | $20M | $24M | $20M | $27M | $55.4K | |
| Shares Outstanding | 11,303,853 | 8,541,745 | 7,373,745 | 89,889,074 | 89,862,683 | 89,862,683 | 88,764,357 | 81,692,954 | 62,100,000 |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $133.3K | $133.3K | $33.3K | $1M | $2M | $1M | $1M | $608.0K | · | |
| Stock-based Comp | $136.2K | · | · | $201.2K | $441.0K | $1M | $2M | $551.7K | $322.2K | |
| Amort. of Intangibles | $133.3K | $133.3K | $33.3K | · | $2M | $1M | $1M | · | · | |
| Other Non-cash | · | $-7M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-5M | $421.7K | $3M | $1M | $-831.1K | $6M | $-644.3K | $-489.2K | |
| CapEx | · | · | · | · | $129.1K | $153.0K | $302.2K | $7.8K | · | |
| Investing Cash Flow | · | · | · | · | $-198.0K | $-2M | $-2M | $-4M | · | |
| Stock Issued | $4M | · | · | · | · | $220.0K | · | $26.0K | $500.0K | |
| Net Stock Activity | $4M | $8M | · | · | · | $220.0K | · | $26.0K | $500.0K | |
| Dividends Paid | · | · | · | · | · | · | · | $1M | · | |
| Financing Cash Flow | $5M | $5M | $-2M | $-2M | $-3M | $2M | $-5M | $9M | $486.3K | |
| Net Change in Cash | $2M | $55.4K | $-2M | $728.6K | $-1M | $-523.0K | $-1M | $4M | $-2.9K | |
| Taxes Paid | · | · | · | $38.9K | $224.1K | $1M | $864.9K | $12.7K | · | |
| Free Cash Flow | · | · | · | · | $1M | $-984.1K | $6M | $-652.1K | · | |
| Levered FCF | · | · | · | · | $86.6K | $-344.4K | $-3M | $358.9K | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.8% | 67.9% | · | · | 63.1% | 72.4% | 70.7% | 60.6% | 38.7% | |
| Operating Margin | -27.8% | 16.7% | · | · | -14.5% | 5.1% | 8.4% | 3.6% | · | |
| Net Margin | -40.6% | 6.1% | · | · | -18.2% | 1.4% | -2.3% | -56.0% | -10483.6% | |
| Pretax Margin | -40.2% | 6.4% | · | · | -18.9% | 2.3% | 0.43% | -53.1% | · | |
| EBITDA Margin | -27.8% | 17.0% | · | · | -14.5% | 5.1% | 8.4% | 3.6% | · | |
| ROA | -93.1% | 14.9% | · | · | -28.0% | 2.2% | -3.4% | -55.4% | -3308.6% | |
| ROE | 69.5% | -10.2% | · | · | -93.7% | 6.0% | -12.7% | -284.7% | 1380.9% | |
| ROIC | -442.9% | -382.0% | · | · | -119.1% | 11.8% | -200.6% | 8.3% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 0.9 | · | · | 0.9 | 1.5 | 0.6 | 0.6 | 0.3 | |
| Quick Ratio | 0.7 | 0.3 | · | · | 0.5 | 0.9 | 0.4 | 0.5 | 0.0 | |
| Debt / Equity | -1.1 | -0.9 | · | · | · | · | 0.1 | 0.1 | · | |
| LT Debt / Equity | -1.1 | -0.4 | · | · | · | · | · | · | · | |
| Interest Coverage | · | 3.8 | · | · | -4.3 | -1.7 | -1.9 | -0.5 | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.3 | 2.4 | · | · | 1.5 | 1.6 | 1.5 | 1.0 | 0.3 | |
| Inventory Turnover | 3.7 | 4.1 | · | · | 4.5 | 5.0 | 11.4 | 14.9 | 0.4 | |
| Receivables Turnover | 7.1 | 9.4 | · | · | 7.7 | 10.9 | 11.3 | 6.8 | 6.3 |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -12.8% | -18.6% | · | · | · | · | · | · | · | |
| EPS YoY | · | -67.4% | · | · | · | · | · | · | · | |
| Net Income YoY | · | -66.5% | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $30M | $35M | · | $29M | $34M | $36M | $35M | $13M | $9.2K | |
| Net Income TTM | $-12M | $2M | · | $-9M | $-6M | $499.6K | $-796.2K | $-8M | $-960.1K | |
| Market Cap | $21M | $38M | · | · | · | · | · | · | · | |
| Enterprise Value | $43M | $52M | · | · | · | · | · | · | · | |
| P/E | -1.5 | 15.7 | · | · | · | · | · | · | · | |
| P/S | 0.7 | 1.1 | · | · | · | · | · | · | · | |
| P/B | -0.9 | -2.3 | · | · | · | · | · | · | · | |
| P / Cash Flow | -8.1 | -7.8 | · | · | · | · | · | · | · | |
| EV / EBITDA | -5.1 | 8.8 | · | · | · | · | · | · | · | |
| EV / Revenue | 1.4 | 1.5 | · | · | · | · | · | · | · | |
| Earnings Yield | -68.3% | 6.4% | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | · | · | 15.6% | · | |
| Annual Payout | · | · | · | · | · | · | · | $1M | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $6M | $8M | $8M | $8M | $10M | $7M | $8M | $9M | $13M | $6M | $6M | $7M | $6M | $9M | $5M | |
| Cost of Revenue | $2M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | $2M | $3M | $3M | |
| Gross Profit | $4M | $2M | $6M | $6M | $6M | $7M | $5M | $6M | $7M | $11M | $5M | $4M | $5M | $5M | $7M | $3M | |
| SG&A Expense | $2M | $4M | $2M | $2M | $1M | $1M | $1M | $903.8K | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $3M | |
| Operating Expenses | $5M | $16M | $4M | $5M | $4M | $5M | $4M | $4M | $5M | $6M | $4M | $15M | $5M | $4M | $5M | $9M | |
| Operating Income | $-567.1K | $-13M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $4M | $1M | $-11M | $363.2K | $705.5K | $2M | $-6M | |
| Interest Expense | · | · | · | · | $370.0K | · | $378.2K | · | $414.2K | $414.0K | · | · | · | · | · | · | |
| Interest Income | $340 | · | · | $379 | $13.9K | · | · | $374 | $387 | · | · | · | · | · | · | · | |
| Other Non-op | $5M | $26M | $-1M | $39.6K | $4M | $14M | $-459.6K | $-749.0K | $5M | $19M | $457.3K | $98.6K | $312.8K | $346.5K | $361.9K | $284.6K | |
| Pretax Income | $-3M | $-15M | $114.2K | $2M | $864.8K | $93.5K | $591.3K | $834.6K | $707.7K | $3M | $547.8K | $-11M | $50.4K | $358.9K | $1M | $-6M | |
| Income Tax | $-13.7K | $-50.1K | $-11.1K | $190.1K | $-11.5K | $-12.2K | $-192.3K | $179.4K | $127.2K | $196.1K | $285.5K | $-108.7K | $-57.4K | $40.5K | $-5.9K | $-9.1K | |
| Net Income | $-3M | $-15M | $125.3K | $1M | $876.3K | $105.7K | $783.6K | $655.2K | $580.5K | $3M | $262.3K | $-11M | $107.9K | $318.5K | $1M | $-6M | |
| EPS (Basic) | $-0.23 | $-1.55 | $0.01 | $0.17 | $0.10 | $0.00 | $0.11 | $0.09 | $0.08 | $0.36 | $0.00 | $-0.12 | $0.00 | $0.00 | $0.02 | $-0.06 | |
| EPS (Diluted) | $-0.23 | $-1.55 | $0.01 | $0.17 | $0.10 | $0.00 | $0.11 | $0.09 | $0.08 | $0.36 | $0.00 | $-0.12 | $0.00 | $0.00 | $0.02 | $-0.06 | |
| Shares (Basic) | 11,303,853 | -17,876,746 | 10,110,114 | 8,928,548 | 8,560,636 | -14,533,140 | 7,373,745 | 7,373,745 | 7,373,745 | -180,073 | 89,889,074 | -179,760,213 | 89,889,044 | 89,889,044 | 89,865,319 | -179,725,321 | |
| Shares (Diluted) | 11,303,853 | -17,894,750 | 10,111,134 | 8,928,548 | 8,577,620 | -14,490,734 | 7,373,745 | 7,373,745 | 7,373,745 | -180,073 | 89,899,074 | · | 89,889,044 | 89,889,044 | 89,865,319 | · | |
| EBITDA | $-567.1K | · | $1M | $2M | $2M | · | $1M | · | · | · | · | · | $363.2K | $705.5K | $2M | · |
Bilanço 26
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $292.1K | $3M | $1M | $1M | $177.9K | $687.9K | $259.4K | · | · | $632.5K | $314.9K | $1M | $1M | $1M | $688.8K | $459.7K | |
| Receivables | $1M | $3M | $7M | $7M | $4M | $5M | $4M | · | · | $2M | $3M | $1M | $2M | $2M | $4M | $4M | |
| Inventory | $3M | $4M | $2M | $2M | $2M | $2M | $2M | · | · | $4M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Prepaid Expense | $1M | $351.0K | $4M | $2M | $2M | $2M | $1M | · | · | $798.0K | $191.2K | $186.1K | · | · | $423.1K | $828.8K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | $435.2K | $611.6K | · | · | |
| Current Assets | $6M | $10M | $21M | $20M | $15M | $16M | $12M | · | · | $12M | $5M | $5M | $6M | $7M | $9M | $9M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | $112.9K | $135.9K | $166.3K | $197.4K | $231.7K | $269.8K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $569.7K | $566.4K | $566.4K | $566.4K | $566.4K | $566.4K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $456.8K | $430.5K | $400.2K | $369.0K | $334.7K | $296.7K | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | $8M | $8M | $8M | $8M | |
| Intangibles | $116.7K | $150.0K | $183.3K | $216.7K | $250.0K | $283.3K | $316.7K | · | · | $416.7K | $6.7K | $7.6K | $2M | $2M | $3M | $3M | |
| Total Assets | $6M | $10M | $21M | $20M | $16M | $16M | $12M | · | · | $12M | $5M | $5M | $17M | $17M | $19M | $20M | |
| Accounts Payable | $4M | $6M | $4M | $5M | $3M | $5M | $5M | · | · | $12M | $4M | $5M | $4M | $5M | $7M | $8M | |
| Short-term Debt | · | · | · | $2M | $5M | $8M | $10M | · | · | $2M | · | · | · | · | · | · | |
| Current Liabilities | $7M | $8M | $4M | $7M | $8M | $17M | $18M | · | · | $14M | $10M | $10M | $10M | $7M | $9M | $10M | |
| Capital Leases | · | · | · | · | · | $8M | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $32M | $33M | $29M | $32M | $31M | $33M | $37M | · | · | $40M | $10M | $10M | $11M | $12M | $14M | $16M | |
| Long-term Debt | · | · | · | · | · | $11M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $25M | · | $25M | $27M | $16M | · | $17M | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $114 | $114 | $114 | $96 | $88 | $87 | $76 | · | · | $76 | $899 | $899 | $899 | $899 | $899 | $899 | |
| Retained Earnings | $-59M | $-56M | $-42M | $-42M | $-43M | $-44M | $-44M | · | · | $-46M | $-24M | $-24M | $-13M | $-13M | $-14M | $-15M | |
| Treasury Stock | $127.5K | $127.5K | $127.5K | $127.5K | $127.5K | $127.5K | · | · | · | $127.5K | · | · | · | · | · | · | |
| AOCI | $-132.2K | $-154.3K | $-35.9K | $-9.8K | $-49.7K | $-47.8K | $5.9K | · | · | $-102.5K | $345.9K | $11.4K | $80.1K | $33.1K | $108.2K | $179.1K | |
| Stockholders' Equity | $-25M | $-23M | $-8M | $-12M | $-16M | $-17M | $-25M | · | · | $-27M | $-5M | $-5M | $6M | $6M | $5M | $4M | |
| Liabilities + Equity | $6M | $10M | $21M | $20M | $16M | $16M | $12M | · | · | $12M | $5M | $5M | $17M | $17M | $19M | $20M | |
| Shares Outstanding | 11,303,853 | 11,303,853 | 11,251,853 | 9,441,853 | 8,572,105 | 8,541,745 | 7,553,818 | · | · | 7,373,745 | 89,889,074 | 89,889,074 | 89,889,074 | 89,889,074 | 89,889,074 | 89,862,683 |
Nakit Akışı 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | · | $26.8K | $300.6K | $301.4K | $303.6K | $306.3K | $459.0K | |
| Stock-based Comp | $116.3K | $116.3K | · | · | · | · | $4.6K | · | · | · | $38.7K | $38.7K | $38.7K | $38.7K | $85.1K | $111.2K | |
| Amort. of Intangibles | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | $33.3K | · | · | $270.2K | $269.3K | $268.2K | · | |
| Other Non-cash | · | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $624.1K | $-2M | $-77.0K | $-822.8K | $-3M | $-237.5K | $-282.0K | $-858.0K | $3M | $-1M | $416.5K | $753.5K | $962.6K | $813.7K | $-739.1K | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3.7K | |
| Stock Issued | $3M | $-160.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-307.6K | $1M | $2M | $1M | $314.7K | $4M | $488.6K | $-597.2K | $1M | $-3M | $58.0K | $-512.5K | $-512.5K | $-512.5K | $-512.5K | $-575.0K | |
| Net Change in Cash | $-2M | $2M | $-452.1K | $1M | $-510.0K | $428.5K | $172.1K | $-823.5K | $278.2K | $394.7K | $-909.6K | $-164.8K | $288.0K | $375.1K | $230.3K | $-1M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $38.9K | $0 |
Kârlılık 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.3% | · | 70.9% | 76.7% | 75.4% | · | 67.2% | · | · | · | · | · | 66.2% | 74.6% | 73.2% | · | |
| Operating Margin | -10.3% | · | 16.0% | 20.0% | 23.8% | · | 14.8% | · | · | · | · | · | 4.9% | 11.1% | 19.3% | · | |
| Net Margin | -46.8% | · | 1.6% | 18.1% | 10.7% | · | 11.0% | · | · | · | · | · | 1.5% | 5.0% | 15.5% | · | |
| Pretax Margin | -47.0% | · | 1.4% | 20.4% | 10.6% | · | 8.3% | · | · | · | · | · | 0.68% | 5.7% | 15.4% | · | |
| EBITDA Margin | -10.3% | · | 16.0% | 20.0% | 24.2% | · | 14.8% | · | · | · | · | · | 4.9% | 11.1% | 19.3% | · | |
| ROA | -23.2% | · | 0.76% | 7.9% | 8.3% | · | 5.4% | · | · | · | · | · | 0.58% | 1.6% | 6.9% | · | |
| ROE | 12.5% | · | -0.75% | -44.3% | -8.7% | · | -8.1% | · | · | · | · | · | 1.4% | 4.3% | 19.6% | · | |
| ROIC | 145.7% | · | 8.3% | 9.9% | 16726.1% | · | -16.5% | · | · | · | · | · | 13.1% | 10.9% | 33.6% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 5.4 | 2.7 | 1.9 | · | 0.6 | · | · | · | · | · | 0.6 | 1.0 | 1.0 | · | |
| Quick Ratio | 0.2 | · | 2.0 | 1.2 | 0.6 | · | 0.2 | · | · | · | · | · | 0.3 | 0.5 | 0.6 | · | |
| Debt / Equity | · | · | -3.0 | -2.2 | -1.0 | · | -0.7 | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -1.0 | · | -3.0 | -2.0 | -0.7 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | 5.3 | · | 2.8 | · | · | · | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.5 | 0.4 | 0.8 | · | 0.5 | · | · | · | · | · | 0.4 | 0.3 | 0.4 | · | |
| Inventory Turnover | 0.5 | · | 1.1 | 0.8 | 1.0 | · | 1.1 | · | · | · | · | · | 0.9 | 0.6 | 0.9 | · | |
| Receivables Turnover | 1.9 | · | 1.5 | 1.7 | 2.2 | · | 2.4 | · | · | · | · | · | 3.8 | 2.0 | 2.3 | · |
Değerleme (TTM) 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $30M | · | $31M | $31M | $33M | · | $35M | · | · | · | $29M | · | $32M | $35M | $38M | · | |
| Net Income TTM | $-94.1K | · | $3M | $4M | $3M | · | $3M | · | · | · | $2M | · | $2M | $1M | $974.0K | · | |
| Market Cap | $15M | · | $27M | $27M | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $39M | · | $52M | $52M | $36M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 25.8 | · | 6.3 | 6.1 | 6.2 | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.5 | · | 0.9 | 0.9 | 0.6 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -0.6 | · | -3.3 | -2.2 | -1.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -7.1 | · | · | · | -24.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -69.3 | · | 40.3 | 32.2 | 18.0 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1.3 | · | 1.6 | 1.7 | 1.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.9% | · | 16.0% | 16.5% | 16.2% | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Gelir | $30M | $35M | $43M | $29M | $34M |
| Brüt Kâr Marjı % | 66.8% | 67.9% | — | — | 63.1% |
| Faaliyet Kâr Marjı % | -27.8% | 16.7% | — | — | -14.5% |
| Net Gelir | $-12M | $2M | $6M | $-9M | $-6M |
| Seyreltilmiş Hisse Başı Kâr | $-1.27 | $0.28 | $0.86 | $-0.10 | $-0.07 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -1.1 | -0.9 | — | — | — |
| Cari Oran | 1.2 | 0.9 | — | — | 0.9 |
| Cari Oran | 0.7 | 0.3 | — | — | 0.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | — | — | — | $1M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 16 dosya · $238K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 11 (+7 önceki Ç'ye göre) | 7 (+4 önceki Ç'ye göre) | 3 (+1 önceki Ç'ye göre) | 1 (-2 önceki Ç'ye göre) | -866K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $133.842 | 71.958 | 56,23% | Hisse senetleri |
| ACT Advisors, LLC. | $30.140 | 151.840 | 12,66% | Hisse senetleri |
| JANE STREET GROUP, LLC | $17.755 | 89.445 | 7,46% | Hisse senetleri |
| SOA Wealth Advisors, LLC. | $16.490 | 83.075 | 6,93% | Hisse senetleri |
| XTX Topco Ltd | $12.162 | 61.270 | 5,11% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.743 | 38.909 | 3,25% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $5.892 | 29.684 | 2,48% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $3.186 | 16.008 | 1,34% | Hisse senetleri |
| StoneX Group Inc. | $3.004 | 15.109 | 1,26% | Hisse senetleri |
| EWA, LLC | $2.725 | 13.727 | 1,14% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.164 | 10.902 | 0,91% | Hisse senetleri |
| Williams & Novak, LLC | $1.989 | 10.020 | 0,84% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $737 | 3.714 | 0,31% | Hisse senetleri |
| BARCLAYS PLC | $175 | 884 | 0,07% | Hisse senetleri |
| HRT FINANCIAL LP | $6 | 34.035 | 0,00% | Hisse senetleri |
| Virtu Financial LLC | $4 | 18.539 | 0,00% | Hisse senetleri |
Şirket yöneticileri 5 içeriden öğrenenler · 3 yöneticiler · 2 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jack Ross | CEO and Chairman | 29 Haziran 2026 D | — | 0 | 0 | $0 |
| Jaime Fickett | Chief Financial Officer | 29 Haziran 2026 D | — | 0 | 0 | $0 |
| Alfred Baumeler | President | 29 Haziran 2026 D | — | 0 | 0 | $0 |
| Knight Therapeutics Inc. | 10% sahip | 11 Haziran 2025 P | — | 0 | 0 | $0 |
| Knight Therapeutics (Barbados) Inc. | 10% sahip | 22 Aralık 2016 J | 17.645.812 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Jack Ross, Gowan Private Equity Inc., Dunhill Distribution Group, Inc., Gowan Capital Inc., Rosscor Brands Corp. | 31 Ekim 2024 | — | İlk başvuru | — | SEC |
| Gowan Private Equity Inc., Dunhill Distribution Group, Inc., Gowan Capital Inc., Jack Ross ×3 başvurular | 21 Aralık 2018 | — | İlk başvuru | — | SEC |
| Knight Therapeutics (Barbados) Inc. ×5 başvurular | 16 Ağustos 2017 | — | İlk başvuru | — | SEC |
| URX Acquisition Trust, KMJZ Investments, L.L.C., Chai Trust Company, LLC, Arbicha Investments, LLC, Casa Vicente LLC ×2 başvurular | 10 Şubat 2016 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 38.909 SH | 08 Ağustos 2026 | Günlük |